Clinical trial
Surveillance of Humira Injection in Korean Patients
NCT01083121
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedSurveillance of Humira Injection in Korean Patients
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Crohn's Diseaseverified · MONDO: Crohn disease
Psoriasisverified · MONDO: psoriasis
Interventions
Sponsors & collaborators
AbbVie (prior sponsor, Abbott)lead sponsor
Eisai Co., Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01083121 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.